Unibest
← Back to patent-cliff list

CAS 33643-46-8

(S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one(2S)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone

Codes: ESKE-004, (IX)270899-2-a, (XI)270899-4-a

Application context (from source-drug indications)

Major depressive disorderEsketamine HydrochlorideSuicidal ideationEsketamine HydrochlorideDepressive disorderEsketamine HydrochlorideAnaesthesiaEsketamine HydrochlorideTreatment-resistant depressionEsketamine HydrochloridePainEsketamine Hydrochloride

Source drugs (routes using this intermediate)

DrugTierExpiry
Esketamine HydrochlorideTier B — Position early2029

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Esketamine HydrochlorideOptimised routesteps: 3total yield: 5.09 g (Esketamine Hydrochloride)
Esketamine HydrochlorideOptimised routesteps: 4total yield: /
Esketamine HydrochlorideOptimised routesteps: 6total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.